Phytoestrogens derived from red clover: An alternative to estrogen replacement therapy?
- 23 March 2005
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 94 (5) , 499-518
- https://doi.org/10.1016/j.jsbmb.2004.12.038
Abstract
No abstract availableKeywords
This publication has 162 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Rapidly rising breast cancer incidence rates among Asian‐American womenInternational Journal of Cancer, 2002
- Long-Term Pharmacokinetics of an Extract of Isoflavones from Red Clover (Trifolium pratense)The Journal of Alternative and Complementary Medicine, 2002
- Expression of prostate‐specific antigen is transcriptionally regulated by genistein in prostate cancer cellsMolecular Carcinogenesis, 2002
- Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cellsLife Sciences, 2000
- Low oestrogen receptor α expression in normal breast tissue underlies low breast cancer incidence in JapanThe Lancet, 1999
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Epidemiology of breast cancer in JapanBreast Cancer, 1995
- Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptorThe Journal of Steroid Biochemistry and Molecular Biology, 1994